Ken Greenberg

Ken Greenberg

Private Equity Investor chez
Venrock Associates
Finance
Consumer Services
Commercial Services

Profil

Ken Greenberg is currently a Partner Partner at Venrock Associates.
Formerly, Dr. Greenberg was Director at Elixir Pharmaceuticals, Inc., Investment Banker at Merrill Lynch Capital Corp., Portfolio Manager at Citadel Advisors LLC from 2020 to 2021, Analyst at Diamondback Capital Management LLC from 2011 to 2012, Principal at MPM BioImpact LLC from 2007 to 2010, Associate at McKinsey & Co., Inc., and Senior Analyst at Ghost Tree Capital LLC from 2013 to 2019.
Education includes an undergraduate degree from Duke University conferred in 1997, a doctorate from the University of Pennsylvania conferred in 2001, and an MBA from The Wharton School of the University of Pennsylvania conferred in 2003.

Postes actifs de Ken Greenberg

SociétésPosteDébut
Private Equity Investor -

Anciens postes connus de Ken Greenberg

SociétésPosteFin
Gestionnaire de Portefeuille-Actions 01/10/2021
Analyst-Equity 01/10/2019
Analyst-Equity 01/12/2012
Private Equity Investor 16/07/2010
Corporate Officer/Principal -
Voir l'expérience en détail de Ken Greenberg

Formation de Ken Greenberg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

95

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Finance

Finance

Finance

Finance

Finance

Commercial Services

Consumer Services

Consumer Services

Miscellaneous

Finance

Consumer Services

  1. Bourse
  2. Insiders
  3. Ken Greenberg
🔇